Ohr Pharmaceutical
+$0.32 (+4.18%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours
Why Robinhood?
You can watch OHRP and buy or sell other stocks, options, and ETFs commission-free!
About OHRP
NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines.
CEO
Dietrich A. Stephan, PhD
Employees
—
Headquarters
Pittsburgh, Pennsylvania
Founded
2009
OHRP Key Statistics
Market cap
32.90M
Price-Earnings ratio
—
Dividend yield
—
Average volume
57.78K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$5.51
52 Week low
$0.89